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INTRODUCTION:  Menetrier’s  disease  is  a rare  premalignant  hypertrophic  gastropathy.  It  is  characterized
by huge gastric  mucosal  folds,  peripheral  edema  due to protein  loss  and  upper  GIT  symptoms  such as
epigastric  pain,  discomfort,  nausea  and  vomiting.
PRESENTATION  OF  CASE:  Female  patient  35  years  old complaining  of severe  epigastric  pain,  dyspepsia,
nausea  and vomiting  for 1 year.  Upper  GIT  endoscopy  and  CT  scan  revealed  thickening  of  gastric  mucosa.
Endoscopic  biopsy  was  non-speciﬁc  but  showed  moderate  grade  dysplasia  and  no  Helicobacter  pylori
infection.  All  laboratory  investigations  were  within  normal  including  serum  albumin.  She  underwent
total  gastrectomy  with  marked  postoperative  improvement  of  symptoms  after  recovery.  Postoperative
pathology  revealed  gastric  fovular  hyperplasia  and glandular  atrophy  which  are  diagnostic  for Menetrier’s
disease.
DISCUSSION:  the preoperative  diagnosis  of  Menetrier’s  disease  in this  case  was  challenged  by  its  unusual
features.  There  were  neither  H. pylori  nor  hypoalbuminemia.  Literature  review  showed  similarcases
which  can  raise  the suspicion  of  the  presence  of an  undescribed  subtype  of  the disease.
CONCLUSION:  Menetrier’s  disease  should  be suspected  in  cases  of upper  GIT  symptoms  and  hypertrophied
gastric  mucosa  with  or without  H. pylori  or hypoalbuminemia.  The  preoperative  diagnosis  could  not  be
conﬁrmed  unless  a whole  mucosal  thickness  biopsy  is  performed.  Surgical  management  is a good  option
when  medical  treatment  fails  to relieve  the  symptoms  and  erase  the  risk  of  malignancy.
©  2015  The  Authors.  Published  by  Elsevier  Ltd.  on behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Menetrier’s disease (MD) is a rare disease that was  ﬁrst
escribed by the French pathologist Pierre Menetrier in 1888 [1].
t is a rare acquired hypertrophic gastropathy leading to dilata-
ion of the mucus-secreting gastric pits (fovula) on the expense
f the gastric glands containing the acid-producing parietal cells
nd pepsinogen-producing chief cells which undergoes atrophy.
hese changes gives the disease it characteristic features of the
uge expansion of gastric mucosa, thick mucus secretion, protein
oss and hypochlorhydria [2].
The disease is more dominant in middle-aged males [3] but
everal authors reported it in pediatric population [4]. The eti-
logy is not well established. Some theories tried to link it to
elicobacter pylori (H. pylori)  infection [5] and enhanced gastric epi-
ermal growth factor receptor signaling by transforming growth
actor-alpha [1]. The clinical picture includes epigastric pain and
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discomfort, nausea, vomiting and peripheral edema due to low
serum albumin levels. MD  has a recognized premalignant poten-
tial [6–8]. Also it can lead to severe uncontrollable protein loss or
upper GIT bleeding [8].
Medical treatment of MD includes proton pump inhibitors, high-
protein diet, eradication of H. pylori [5], cetuximab (monoclonal
antibody) [6] and octreotide long-acting release [4]. Also total and
partial gastrectomy are attempted in managing resistant cases.
We describe a case of MD with an unusual presentation that was
recently managed in our hospital.
2. Presentation of case
Female patient 35 years old, married with 2 children was  pre-
sented to our outpatient clinic complaining of severe epigastric
pain, dyspepsia, nausea and vomiting for 1 year. Her condition
started with gradual onset and showed progressive course. She
went to her primary care giver at the onset of her condition and
was diagnosed to have chronic gastritis. She underwent multiple
courses of proton pump inhibitors and Prokinetic medications with
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 2. Gross appearance of the resected stomach after the total gastrectomy reveal-
ing huge gastric folds.ig. 1. CT scan of the abdomen with IV contrast revealing marked mucosal thicken-
ng  (arrow) of the fundus, body and antrum of the stomach.
o signiﬁcant improvement. She has no relevant family, medical or
urgical history.
Upper GIT endoscopy was done. It revealed unhealthy mucosal
rowth occupying all the fundus and the body of the stomach.
istopathological examination revealed tubulovillous adenoma
ith moderate grade dysplasia with no evidence of H. pylori.
bdominal CT scan (Fig. 1) revealed marked mucosal thickening
f the fundus, body and antrum of the stomach with few spared
reas in-between. Uniform enhancement after contrast adminis-
ration and the preserved fat planes suggested benign nature of
he mucosal pathology. Laboratory investigations including CBC,
iver and kidney functions in addition to tumor markers (CEA–CA
9–9) and Cytomegalovirus (CMV) were all within normal range. It
s worthy to state that the serum albumin was 4 g/dL.
On 18th April 2015, the patient underwent total gastrectomy
nd esophago-jejunal anastomosis after laparoscopic assessment
hat did not reveal any other intra-abdominal pathology. The
atient underwent an uneventful postoperative period except for
ransient drop in serum albumin level on the third and fourth post-
perative days (2.7 and 3.1 g/dl respectively). She was discharged
n the 8th postoperative day. 3 months follow up showed marked
mprovement of her health status with no signs of recurrence of
er complaint.
Histopathological examination of the resected specimen
evealed diffuse huge rugea of the whole gastric body showing
erebriform appearance (Fig 2). Antral region appeared grossly free.
icroscopic examination revealed fovular hyperplasia reaching the
uscularis mucosa with evident glandular atrophy conﬁrming the
iagnosis of MD  (Fig 3). Both proximal and distal cut margins were
ree.
. Discussion
The diagnosis of MD remains an everlasting challenge. This is
ue to the rare nature of the disease and the lack of clear diagnostic
riteria [2,8].
We  could not ﬁnd an exact estimate of MD incidence in lit-
rature except that is “rare”. In our experience, it is so rare that
ach new case is usually encountered at ﬁrst by an endoscopist
ho did not see a similar case before. This explains why the diag-
osis of the huge gastric folds can be mixed with other types
f unhealthy growths like gastric polyps or polyposis syndromes
2], Hypertrophic hypersecretory gastropathy with protein loss [9],
ollinger–Ellison syndrome and gastric malignancies [8].Fig. 3. Microscopic examination of the resected specimen showing the character-
istic features of Menetrier’s disease: fovular hyperplasia reaching the muscularis
mucosa with evident glandular atrophy.
Rich et al. [2], proposed an algorithm for the diagnosis of MD
that rely on clinicohistopathological analysis of the following cri-
teria: upper GIT endoscopy with gastric pH, appropriate laboratory
tests (CBC, serum albumin, serum gastrin, H. pylori and CMV) and
full thickness mucosal biopsy. This is to be correlated with clas-
sic clinical features of epigastric pain, nausea and vomiting due to
the local effect of the huge gastric folds, in addition to peripheral
oedema due to the protein losing nature of the disease that leads
to Hypoalbuminemia.
The previous criteria is only useful in dealing with typical cases
of MD.  In our case, as well as in several cases in literature, the
diagnosis was obscure due to the presence of variant clinical pre-
sentations.
Although hypoalbuminemia is considered as a corner stone
in the diagnosis, our case did not show it on neither symp-
toms (peripheral edema) nor laboratory values. Her albumin levels
remained within normal ranges except for a transient drop in the
postoperative period, which we believe to be due to dilution effect
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f postoperative ﬂuid therapy. The same feature of MD  with nor-
al  albumin level could be found in literature in both adult [3] and
ediatric [4] population suggesting the presence of a subtype of the
isease that should be further studied.
Pinch biopsy in our case could not establish the diagnosis. The
istopathological diagnoses of MD needs a deeper snare biopsy
with or without electrocautery) to examine the full thickness of
he hypertrophied mucosa for fovular hyperplasia and glandular
trophy [2]. Sanchez et al. [10] reported a case of MD  in which diag-
osis was made by an invasive laparoscopic-assisted full thickness
iopsy after failure of multiple endoscopic pinch trials.
Another distinctive feature of our case is that it was not asso-
iated with H. pylori infection. Although many authors proposed
hat H. pylori plays an essential role in the pathogenesis process of
D [5], many cases were reported without infection rendering this
ausal relation unsupported [3,4]
Gastrectomy is a well-established treatment of MD  due to the
igh rate of failure of medical treatment and the risk of malignant
ransformation. Surgical treatment in our case was justiﬁed by the
ong duration of the disease (1 year), severe symptoms resistant to
onservative medical treatment and the presence of dysplasia in the
ndoscopic biopsy that represented an alarming sign of impending
alignancy. Also the extensive nature of the pathology affecting
he majority of the stomach encouraged the operators to opt for
otal gastrectomy. While the antrum appeared grossly free, its thick
all in CT scan and during surgical exploration pushed towards the
ecision of total gastrectomy. The added beneﬁt of proximal gas-
rectomy could not balance the risk of performing the esophageal
nastomosis with a suspiciously unhealthy antrum [8]. This was
upported by reports of MD that affected the antrum as well as the
undus and the body of the stomach [3].
. Conclusion
MD  should be suspected in cases of upper GIT symptoms and
ypertrophied gastric mucosa with or without H. pylori or hypoal-
uminemia. The preoperative diagnosis could not be conﬁrmed
nless a whole mucosal thickness biopsy is performed. Surgical
anagement is a good option when medical treatment fails to
elieve the symptoms and erase the risk of malignancy.
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